|
"tseng tseng t c"的相关文件
显示项目 1-5 / 5 (共1页) 1 每页显示[10|25|50]项目
國立成功大學 |
2022 |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, S.-C.;Cheng, P.-N.;Liu, C.-H.;Yang, H.-C.;Su, T.-H.;Tseng, Tseng T.-C.;Chen, P.-J.;Kao, J.-H.;Liu, C.-J. |
國立成功大學 |
2022 |
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
|
Lin, C.-L.;Tai, C.-M.;Huang, J.-F.;Liu, C.-J.;Chen, H.-F.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Wang, C.-C.;Weng, S.-H.;Tseng, Tseng T.-C.;Kao, J.-H. |
國立成功大學 |
2020 |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang, W.-Y.;Chiu, Y.-C.;Chiu, F.-W.;Hsu, Y.-C.;Tseng, Tseng T.-C.;Cheng, P.-N.;Yang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Liu, C.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
國立成功大學 |
2017 |
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells
|
Lin, G.-L.;Ting, H.-J.;Tseng, Tseng T.-C.;Juang, V.;Lo, Y.-L. |
國立政治大學 |
2015-01 |
What can we learn from hepatitis B virus clinical cohorts?
|
Lin, Chih-Lin;Tseng, Tseng T.-C.;Kao, J.-H.; 林志陵 |
显示项目 1-5 / 5 (共1页) 1 每页显示[10|25|50]项目
|